Concepedia
Statistics
Publications
16
Citations
3.8K
H-Index
15
Active since
1989
Affiliations
Research & Development Corporation(Current)
Eli Lilly (United States)
University of Miami
Massachusetts General Hospital
University of Texas Health Science Center at Dallas
Kendall M. Mohler is an author at Research & Development Corporation specializing in immunology, medicine, and inflammation.
Top concepts
MedicineImmunologyInflammationAutoimmunityImmune RegulationAutoimmune DiseaseChronic InflammationPathologyCell BiologyImmunotherapy
Publications per year
1989–1999
Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein
Larry W. Moreland, Scott W. Baumgartner, Michael Schiff et al. · New England Journal of Medicine · 1997 · 1.6K citations · Full text
Immunology, Immune Regulation, Pathology +19
TNF Receptor-Deficient Mice Reveal Divergent Roles for p55 and p75 in Several Models of Inflammation
Jacques J. Peschon, Dauphine Torrance, Kim L. Stocking et al. · The Journal of Immunology · 1998 · 706 citations · Full text
Inflammatory Lung Disease, Lung Inflammation, Immunology +19
Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
Kendall M. Mohler, Paul R. Sleath, Jeffrey N. Fitzner et al. · Nature · 1994 · 599 citations
Inflammation, Immunotoxicology, Medicine +8
CD40/CD40 ligand interactions are required for T cell‐dependent production of interleukin‐12 by mouse macrophages
Mary K. Kennedy, Kathleen S. Picha, William C. Fanslow et al. · European Journal of Immunology · 1996 · 178 citations
Induction of B cell costimulatory function by recombinant murine CD40 ligand
Mary K. Kennedy, Kendall M. Mohler, Kurt Shanebeck et al. · European Journal of Immunology · 1994 · 146 citations
Autoimmune Disease, Allergy, Adaptive Immune System +15
1–5 of 16